Mutagen Sensitivity and Genetic Variants in Nucleotide Excision Repair Pathway: Genotype-Phenotype Correlation

• Published in: Cancer epidemiology, biomarkers & prevention Vol. 16; no. 10; pp. 2065 - 2071
• Main Authors: Lin, Jie, Swan, Gary E., Shields, Peter G., Benowitz, Neal L., Gu, Jian, Amos, Christopher I., de Andrade, Mariza, Spitz, Margaret R., Wu, Xifeng
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA American Association for Cancer Research 01.10.2007
• Subjects: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Adult; Alleles; Biological and medical sciences; Carcinogens; DNA Repair - genetics; Female; Gene Frequency - genetics; Genetic Variation - genetics; Genotype; Haplotypes - genetics; Humans; Linkage Disequilibrium - genetics; Male; Medical sciences; Middle Aged; Multigene Family - genetics; mutagen sensitivity; Mutagenicity Tests; nucleotide excision repair (NER); Phenotype; Polymorphism, Single Nucleotide - genetics; polymorphisms; Sister Chromatid Exchange; Statistics as Topic; Tumors; Twins, Dizygotic - genetics; Twins, Monozygotic - genetics; Correlation; Phenotype; Sensitivity; Cancerology; Typing; Genetic variant; Genotype; Nucleotide excision repair; Mutagen
• ISSN: 1055-9965; 1538-7755
• DOI: 10.1158/1055-9965.EPI-06-1041

The rationale behind gene-disease association studies is that genetic variants (polymorphisms) result in alterations in intermediate phenotypes. However, genotype-phenotype correlations have not been established for most polymorphisms. In this study, we correlated genotype data of genes involved in the nucleotide excision repair pathway with mutagen sensitivity phenotype, quantified by benzo( a )pyrene diol epoxide (BPDE)-induced chromatid breaks in peripheral blood lymphocytes in 422 healthy subjects recruited into a twin study that included 138 pairs of monozygotic twins, 51 pairs of dizygotic twins, and 44 siblings. Among a panel of single nucleotide polymorphisms examined, we found that BPDE sensitivity was modified by individual polymorphisms in XPC, RAD23B , and XPA genes. Specific haplotypes and diplotypes of XPC also modified BPDE sensitivity profiles. In addition, a more consistent and stronger correlation was observed between mutagen sensitivity phenotype and the combination of multiple polymorphisms in the nucleotide excision repair pathway. Specifically, when XPC -PAT, XPC Lys939Gln, XPA A23G, and RAD23B Val249Ala were analyzed together, we observed a significant dose-response relationship between increasing mutagen sensitivity with increasing number of adverse alleles: mutagen sensitivity for those carrying zero to two, three to five, and six or more adverse alleles were 0.64, 0.68, and 1.06, respectively ( P for trend = 0.008), and the results remained significant after adjusting for multiple comparisons. Using individuals carrying zero to two adverse alleles as the reference group, the risks of being mutagen sensitive (mutagen sensitivity values greater than the median) were 1.05 (95% confidence interval, 0.68-1.64) and 4.48 (95% confidence interval, 1.21-16.61) for those carrying three to five and six or more adverse alleles, respectively. Analyses of the effects of genotype combinations yielded similar results. These findings underscore the importance of assessing the collective effects of a panel of polymorphisms in the same pathway in modulating mutagen sensitivity. As risk assessment for cancer risk is moving toward a multigenic pathway-based approach, future genotype-phenotype correlation studies should also investigate the combined effects of multiple genetic variants. (Cancer Epidemiol Biomarkers Prev 2007;16(10):2065–71)